Chlorpromazine Hydrochloride Injection
Product Images NDC 70771-1779

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 70771-1779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 01)

25 mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 01)
This is a description for Chlorpromazine Hydrochloride Injection, USP. It is intended for deep intramuscular use and comes in a single-dose vial with a volume of 1mL. The medication should be protected from light, and any unused portion should be discarded. It is manufactured by Zydus Lifesciences Ltd. in Vadodara, India.*
FDA Label Image

25mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 02)

25mg/ml (Bcbd52b5 2981 407b B260 0568efab3890 02)
This description provides information about a pharmaceutical product called Chlorpromazine Hydrochloride Injection, USP. It is intended for deep intramuscular use and comes in single-dose vials containing 25 mg/mL of the active ingredient. The product should be discarded if any unused portion remains. The text also mentions the composition of the injection solution and provides instructions on storage conditions. The product is manufactured by Zydus Lifesciences Ltd in Vadodara, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.